Advisor Partners II’s Charles River Laboratories CRL Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | $469K | Buy |
2,393
+63
| +3% | +$12.3K | 0.02% | 749 |
|
2023
Q2 | $490K | Buy |
2,330
+38
| +2% | +$7.99K | 0.02% | 616 |
|
2023
Q1 | $463K | Buy |
2,292
+164
| +8% | +$33.1K | 0.03% | 578 |
|
2022
Q4 | $464K | Buy |
2,128
+277
| +15% | +$60.4K | 0.03% | 543 |
|
2022
Q3 | $364K | Buy |
+1,851
| New | +$364K | 0.03% | 555 |
|